Session :

Time :

Date :

Room :

Organiser(s) :



Jody Cox, Vice President, Federal and International Affairs, Canadian Generic Pharmaceutical Association, Vice President, Biosimilars Canada


Trade negotiations have traditionally placed the protection and enforcement of intellectual property for medicines as their primary objective in the pharmaceutical sector, ignoring the distorting effects and broad implications created by such an exclusive approach.

Building more inclusiveness into the global trading system for medicines is needed to support the UN Sustainable Development Goal of ensuring healthy lives and promoting well-being for all at all ages.

This working session will investigate how to build greater inclusiveness into the global trading system for medicines by addressing escalating health care costs and an aging population and recognizing the important role of generic and biosimilar medicines businesses.

Speakers will examine ways to use the provisions of existing agreements to maximize inclusiveness in the trade of medicines, and also discuss the need for new types of trade agreements and trade-promotion mechanisms that truly foster and enhance the global trade of medicines.


  • Terry Creighton, Vice President, Global Policy, Teva Pharmaceuticals
  • Sergio Napolitano, Legal Affairs and Trade Director, Medicines for Europe
  • Nawel Rojkjaer, Senior Director, International Affairs, Mylan Pharmaceuticals